Several other genes, including CIDEP, FABP3, FFAR, CCL2 and PRKCZ, have previously been identified to be differentially methylated in PBLs from diabetic patients[48–51] and could thus be of potential in the identification of metabolic diseases. Here, CCL2 is linked to metabolic disease.